HUTCHMED (China) (HCM) Interest & Investment Income (2015 - 2021)
HUTCHMED (China) (HCM) posted quarterly Interest & Investment Income of $1.9 million for Q4 2021, up 280.28% quarter-over-quarter from $492000.0 in Q1 2021.
HUTCHMED (China) (HCM) Interest & Investment Income (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Interest & Investment Income for 6 consecutive years, with $1.9 million the latest figure, recorded in Q4 2021.
- In Q4 2021, Interest & Investment Income changed N/A year-over-year to $1.9 million; the TTM figure through Dec 2021 stood at $3.9 million (changed N/A YoY), while the FY2025 annual figure was $49.9 million, up 24.44% from the prior year.
- Interest & Investment Income advanced to $1.9 million in Q4 2021 per HCM's latest filing, from $492000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.9 million in Q4 2021 and bottomed at $196000.0 in Q1 2020.
- Historically, Interest & Investment Income has averaged $1.2 million across 4 years, with a median of $1.4 million in 2019.
- Annual changes were most pronounced in 2020 — Interest & Investment Income tumbled 88.31% — and 2021, when it surged 151.02%.
- HUTCHMED (China)'s Interest & Investment Income stood at $1.5 million in 2018, then dropped by 9.06% to $1.4 million in 2019, then tumbled by 85.85% to $196000.0 in 2020, then soared by 854.59% to $1.9 million in 2021.
- Business Quant data shows HCM's Interest & Investment Income at $1.9 million in Q4 2021, $492000.0 in Q1 2021, and $196000.0 in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | HUTCHMED (China) | 2.17 Bn | 2.17 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1.87 Mn |
| Mar 31, 2021 | 492,000.00 |
| Mar 31, 2020 | 196,000.00 |
| Jun 30, 2019 | 1.39 Mn |
| Mar 31, 2019 | 1.68 Mn |
| Jun 30, 2018 | 1.52 Mn |
| Mar 31, 2018 | 1.27 Mn |
| Jun 30, 2016 | 385,000.00 |
| Jun 30, 2015 | 379,000.00 |